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The goal of this study was to investigate the frequency of gout-specific ultrasonography findings in a cohort of
hyperuricemic patients with various musculo-skeletal complaints.
A blinded examiner regarding the patients’ clinical and laboratory assessment performed standardized ultrasound
examinations of 12 joints in 74 individuals with diverse musculo-skeletal complaints. Gout-specific changes were
assessed and combined with the patients’ medical history (diagnosis gout vs. non-gout) and laboratory values of
hyperuricemia.
Of 74 patients, 58 (mean age 55 yrs) had hyperuricemia (serum uric acid levels > 7 mg/dl/420 μmol/L). Of those,
27 (47%) had a history of gout attacks.
In total, 888 joints were examined by ultrasound. With 44/324 joints (14%) the pathological finding most often
found in joints of gout patients was the double contour sign compared to 29/372 joints (8%) in patients with
asymptomatic hyperuricemia and 2/192 joints (1%) in normouricemic controls.
In patients with gout, the ultrasound showed pathological findings in 67/324 joints (21%). In 26/39 (67%) previously
affected joints, gout-specific sonographic indications were found. With regard to the first metatarsophalangeal joint,
sonographic pathologies were detectable in 16/22 (73%) so far asymptomatic joints on the contralateral.
Ultrasonographic gout-specific signs are not only found in joints affected by gout attacks, but often also in the
corresponding contralateral, asymptomatic joint. Patients with asymptomatic hyperuricemia already showed
sonographic features implicating an as yet “silent” precipitation of urate crystals. As the examined cohort represents
patients at high risk, further research for gout-specific findings is indicated, especially for hyperuricemic patients.
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Gout is one of the most common forms of inflammatory
arthritis in men with increasing prevalence. It is typically
characterized by two clinical phases. Normally, the initial
phase of the disease is marked by acute attacks of active
synovitis, which spontaneously resolves with asymptomatic
periods between flares (intercritical gout). Without ad-
equate treatment of hyperuricemia (HU) as the underlying
condition, it may transit into a chronic (tophaceous) dis-
ease with polyarticular manifestations and crystal depos-
ition in soft tissues, so called tophi (Neogi 2011). Although
Neogi et al. found that up to 2/3 of patients with at least
one gout attack in the previous year had recurrent attacks* Correspondence: m.reuss-borst@rehaklinik-am-kurpark.de
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reproduction in any medium, provided the orig(Neogi et al. 2006), in daily practice, patients often present
the “intercritical phase” with unspecific musculo-skeletal
complaints mainly associated with other concomitant
diseases such as diabetes mellitus or arterial hypertension
to their general practitioners/doctors.
In this early phase of disease, it may be difficult or
even impossible to confirm the diagnosis of gout, in par-
ticular since the definitive confirmation of gout rests on
the identification of monosodium urate (MSU) crystals
in the synovial fluid (Zhang et al. 2006).
In the last decade, the role of musculoskeletal ultra-
sound (US) in investigating MSU deposition is rapidly
evolving since various findings have been described as
specific for gout such as the hyperechoic enhancement
of the superficial margin of the hyaline cartilage (double
contour sign) (Thiele & Schlesinger 2007; Chowalloor &
Keen 2013). Thus these new imaging techniques mightis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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early structural damage. However, little is known about
whether gout-specific signs are only identified in clinically
involved joints, or also in as yet (clinically) unaffected
joints. In addition, we do not know whether the “silent”
MSU deposition might be responsible for those unspecific
symptoms in patients with HU and unspecific musculo-
skeletal problems. Furthermore, there is still no answer to
the question if ultrasonographic signs of MSU precipita-
tion are predictable in patients with HU for the develop-
ment of clinically manifest gout.
Since HU is the most important risk factor for gouty
arthritis and a common finding in men (21,1%) and women
(4,7%) with often concomitant unspecific joint complaints
(Zhu et al. 2011), US might be a valuable tool to identify
hyperuricemic patients at risk for gouty arthritis.
In order to investigate the usefulness of US in patients
with HU and (unspecific) various joint complaints we
performed a prospective blinded study using patients
with HU as well as normouricemic controls.
Material and methods
Patients
74 adult patients in an inpatient rehabilitation program for
musculo-skeletal problems were included in the study. All
patients were considered to be at high risk for occupational
disability and therefore underwent an inpatient rehabilita-
tion program for the statutory pension fund because of
their various joint and bone complaints. Demographic,
clinical and laboratory characteristics such as uric acid,
blood glucose level, cholesterol, triglycerides and GGT of
each patient were recorded. All patients filled in a ques-
tionnaire about the history of previous gout attacks, risk
factors for gout and individual knowledge about nutritional
recommendations. A detailed clinical examination with
special emphasis on joint pathology and presence of
clinical tophi was performed in all patients by an expert
clinical rheumatologist recording swelling and tenderness
of joints.
Prior to inclusion, all patients provided informed con-
sent for participation. The study was in accordance with
the declaration of Helsinki and approved by the ethical
committee of the State Chamber of Physicians of Bavaria.
Ultrasonographic examinations
US examinations were performed independently by a sec-
ond (trained, DEGUM certified) rheumatologist who was
blinded to the clinical and laboratory data of the patients.
All US examinations were performed using a MyLab 70
XVG (Esaote SpA, Genoa, Italy) equipped with 2 multi-
frequency linear probes operating at a frequency spectrum
from 7 to 15 MHz.
Standardized examinations were carried out in 12 joints (6
joints bilaterally) for each patient: first metatarsophalangealjoints (MTP I), upper ankle (talonaviculare) joints, knee
joints, wrists, thumb basal joints (MCP I) and elbows. All
studies were performed in two dimensions by scanning
across the joints and moving the probe from medial to
lateral and from distal to proximal. Each site was scanned in
gray scale mode to detect structural changes and Power
Doppler technique to detect abnormal blood flow.
Beside detection of synovitis and erosions, gout-related
lesions were investigated in each joint, including the
presence of the double contour sign (DC) and peri-/
intraarticular hyperechoic cloudy areas (HC).
DC was defined as focal or diffuse echogenic enhance-
ment on the superficial margins of the joint cartilage. HC
was characterized as peri-/intraarticular heterogeneous
masses composed of hyper- or hypoechoic material some-
times possessing posterior shadows. Synovialitis was
defined as the presence of either synovial fluid and/or syn-
ovial hypertrophy, which is characterized by abnormal
hypoechoic intraarticular tissue that is poorly compressible
and may exhibit a Doppler signal (show microvascular
blood flow). Erosions were defined as intra-articular
discontinuity of the bone cortex that were visible in at least
two perpendicular planes (Thiele & Schlesinger 2007;
Grassi et al. 2006; Perez-Ruiz et al. 2009). Sonographic
pictures of each location in every patient were stored.
The clinical assessor combined clinical and sonographic
data obtained in the study. A descriptive analysis of the
data was performed. Demographic and clinical features
were summarized as mean values for continuous variables
and absolute frequencies or proportions (percentages) for
categorical variables. Pairwise comparisons between fre-
quencies of clinical data in different groups of patients
were analyzed using the chi-square-test.
Results
Demographic and clinical characteristics
74 patients at the mean age of 54 years were studied.
The most frequent main diagnosis on admission was
back pain (61%) classified as M45 (35%), M53 (18%) or
M51 (8%) according to the ICD-10-GM (International
Classification of Disease). In 11/74 patients (15%) shoulder
problems were mentioned as main diagnosis, 18/74 (24%)
had other musculo-skeletal problems coded as M-diagnosis
according to the ICD.
Gout as the underlying disease (M10) was mentioned in
0/27 (0%) patients with a history of gout by the admitting
physician as main diagnosis. As first concomitant diagnosis
it was mentioned in 3/27 (11%) cases, as second concomi-
tant diagnosis in 8/27 (30%) and third concomitant diagno-
sis 4/27 (15%) cases. The clinical and laboratory chara
cteristics of the study population are shown in Table 1.
Of 58 hyperuricemic patients (including those with a
history of gout), 40 patients had been told by their primary
physician that serum uric acid (SUA) had been elevated in
Table 1 Clinical characteristics of the study population
Clinical and laboratory characteristics Gout (n = 27) Asymptomatic hyperuricemia (n = 31) Normouricemic controls (n = 16)
Mean Age, yrs 54,2 54,7 52,5
Male,% 81,5 61,3 56,2
Mean serum uric acid value in mg/dl (mmol/l)) 7,7 (458,1) 8,1 (481,9) 5,2 (309,4)
BMI (kg/m2) 30,0 31,5 28,6
Triglycerides in mg/dl (mmol/l)) 199,0 (2,269) 201,3 (2,295) 128,6 (1,466)
Cholesterol in mg/dl (mmol/l) 215,9 (5,613) 232,7 (6,05) 224,1 (5,827)
Glucose in mg/dl (mmol/l) 101,3 (5,622) 105,9 (5,877) 94,4 (5,239)
GGT (U/l) 103,0 61,9 38,9
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(65%) had never got information about life-style modifica-
tion e.g. restriction of purine-rich food. Nevertheless, 41/58
(71%) patients knew that excessive drinking of beer and
eating of grilled meat might trigger a gout attack, but only
7/58 (12%) knew about the urate-elevating effect of
fructose-rich drinks. 27/58 (47%) investigated subjects had
a previous history of gout attacks. Details of the involved
joints and frequency of attacks are depicted in Figure 1. Of
the 27 patients with gout 6 (22%) underwent urate lowering
treatment during the study period, 10 (37%) had undergone
it in the past and 11 (41%) had never been treated.
16 patients with similar musculo-skeletal symptoms, but
with SUA levels < 7 mg/dl were also included in this study.
Ultrasonographic results in HU and normouricemic
controls
The results of the ultrasonographic examinations are
shown in detail in Figure 2 and Additional file 1: Table S1,
Tables 2 and 3. In total, 888 joints in 74 patients wereFigure 1 Characteristics of gout attacks in our study population. A) In
MTP I and foot were the joints most often affected. C) Most patients repor
attacks had ocurred more than 2 years before the study.investigated. The DC sign was the pathological finding de-
scribed most often, in particular in 44/324 joints (14%) of
gout patients, 29/372 (8%) joints of HU patients and 2/192
(1%) normouricemic controls. Thus, DC signs were signifi-
cantly more often described in joints of gout patients than
in joints of HU patients (Χ2(1) = 6,172, p = .026) and
normouricemic controls (Χ2(1) = 23,342, p < .001). HU pa-
tients also showed significantly more DC signs than
normouricemic controls (Χ2(1) = 11,121, p = .001).
In patients with gout, pathological ultrasonographic find-
ings were detectable in 67/324 joints (21%). When corre-
lated with the clinically affected localization, in 26/39
(67%) gout-specific sonographic findings were found by the
blinded investigator. With regard to the MTP I, sono-
graphic pathologies were detectable in 16/22 (73%) MTP I
joints on the contralateral, till now asymptomatic side. In
only 3/26 (12%) previously affected MTP I joints, the sono-
graphic findings were judged to be normal. In 4/27 (15%)
patients DC signs were found in up to the present un-
affected knees, all four patients having a history of previousour population more men than women were affected by gout. B)
ted having had less than 5 gout attacks so far D) Most reported gout
Figure 2 US findings of MSU deposits in joints. A) the typical hyperechoic enhancement on the cartilage surface (“double contour sign”)
B) intra-articular hyperechoic clouds C) bone erosion and D) active synovitis with E) a periarticular power signal.
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patients, hyperechoic clouds were also described in so far
unaffected wrists (Additional file 1: Table S1).
In patients with HU without history of typical gout, 52
of 372 investigated joints (14%) showed pathological find-
ings with US. In only 9/31 patients (29%) with HU, the
sonography in the investigated joints panel was judged to
be completely normal. The DC sign was found in 17/62
(27%) investigated MTP I joints. In 17/31 patients (55%)
the investigator described echogenic structures and/or
double contour signs in MTP I joints; in 5/31 patients a
synovialitis and erosions were found in the MTP I joints
(Table 2).
Normouricemic controls
In 11/192 investigated joints (6%) pathological findings
without clinical correlates were reported (Table 3).
Discussion
The majority of our patients with musculo-skeletal prob-
lems and HU had previously been informed about elevated
serum urate levels by their primary care physicians. Beer
and grilled meat are known to be risk factors for high
serum urate levels by most patients. However, less than
half of these patients had received certain diet and lifestyle
recommendations in the past for lowering serum urate
levels, which is in accordance with previous studies(Doherty et al. 2012). Similarly, only a minority (12%) knew
about the urate-elevating effects of soda (fructose sweet-
ened) drinks. This finding underlines the necessity for
more information on diet and lifestyle measures even if
clinical trials on non-pharmacologic interventions have
only reported a 10-18% decrease in serum urate (Khanna
et al. 2012).
In our study, we found a surprisingly high percentage
of patients with a gout history among the hyperuricemic
population, which might at least be partially explained
by the selected study population of patients with long-
standing numerous musculo-skeletal problems. Those
patients were admitted to our rehabilitation unit by their
primary care physician because of their high risk for oc-
cupational disability. In addition, our study population
exclusively comprised manual workers (“blue collar”
jobs) with mostly low socioeconomic status. Although
gout was mentioned as concomitant diagnosis in >50%
of the patients with a history of gout attacks, gout was
never mentioned as main diagnosis in our study popula-
tion. In 12 of 27 (44%) patients with a history of gout,
this diagnosis was not at all documented by the admit-
ting physician. Thus, gout is probably still considered to
be a benign disease by many doctors, not worth being
mentioned in the admitting letter. Correspondingly, only
6 of 27 (22%) gout patients currently received a urate-
lowering treatment with none of the medically treated
Table 2 Sonographic findings of 31 patients with (asymptomatic) hyperuricemia
Pat.-Nr. MTP I R MTP I L Ankle R Ankle L Knee R Knee L Wrist R Wrist L TBG R TBG L EB R EB L
01 HC, S DC
02
03 HC HC HC HC HC
04 DC, HC DC, HC, S DC
05
06 DC DC, HC DC DC
07 E
08 S S
09 DC, HC DC DC
10 DC DC DC





16 DC, HC, S
17 S S, E
18
19 DC, HC, S, E HC E HC
20 DC, S, E
21 DC, HC, S, E DC, HC, S
22 HC
23 DC DC




28 HC, S DC DC DC
29
30 DC, HC, E DC, HC, S
31 HC, S
Abbreviations: DC double contour sign, HC hyperechoic clouds, E erosions, S synovitis.
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ommended by current guidelines (Khanna et al. 2012).
Hence, one first important result of our study is that
gout is quite frequent, but underreported in the diagnosis
in the admission letter and furthermore remains under-
treated or even untreated, particularly in this study popu-
lation with longstanding musculoskeletal problems and
with a high risk of occupational disability.
Claessen et al. (2010) have similarly investigated the
role of SUA as a predictor of occupational disability.
Musculoskeletal disorders cause the largest proportion
of all cases of disability pension among manual workers.
An age-adjusted analysis revealed a strong positive associ-
ation between elevated SUA concentration and occupationaldisability due to musculo-skeletal disorders in a cohort of
16532 male construction workers in Germany who under-
went occupational health examinations from 1986 to 1992
and were followed until 2005.
In accordance with this, our study population comprised
patients with a longstanding history of musculo-skeletal
complaints. It is known that crystallization of MSU is
facilitated in osteoarthritic joints, which might explain the
high prevalence of pathological findings in our selected
population.
One might further speculate that the unspecific muscu-
loskeletal problems in our study population might at least
partially by due to subclinical MSU crystal deposition for
example in the small joints of the spine. This may be in
Table 3 Sonographic findings of 16 patients with normal serum urate values












12 DC HC E
13
14 S, E S,E
15 S, E
16
Abbreviations: DC double contour sign, HC hyperechoic clouds, E erosions, S synovitis.
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(2012) that reported on axial gout as a common feature of
chronic gouty arthritis.
With regard to the sonographic examinations performed
by a blinded rheumatologist we found a high prevalence of
gout-specific lesions in so far clinically involved, but –more
interestingly also – in so far clinically uninvolved joints.
This applies in particular for the MTP I joints as gout
index joints. The presence of MSU crystals in the synovial
fluid from asymptomatic individuals with HU has already
been demonstrated by polarized light microscopy more
than 30 years ago (Rouault et al. 1982). Thus, it is not sur-
prising that with better imaging techniques, gout specific
structural lesions become visible. Serum urate seems to
have a preference to crystallize on the surface of (damaged)
cartilage with the normal components of cartilage chon-
droitin sulfate and phosphatidylcholin facilitating nucle-
ation and crystallization of MSU explaining the high
prevalence of the DC signs in patients with gout, but also
HU. In particular, the DC sign has not been described in
other disease entities until now and must be interpreted as
highly specific for gout with a specificity >98% (Ottaviani
et al. 2012). Our results are in accordance with a previous
study of Pineda et al. (Pineda et al. 2011) who found the
DC sign in 25% of the first MTP joints from hyperuricemic
individuals.
The high prevalence of pathological US findings in our
study population might support the hypothesis that US
can help to identify patients with HU who have a high
risk for developing clinically manifest gout. With these
patients, it might be worthwhile initiating long-termurate-lowering therapy early in the course of disease, in
particular since we know that uric acid is a danger signal
of increasing risk for osteoarthritis through NLRP
inflammasome activation leading to the production of
IL-18 and IL-1ß. Recently, Denoble et al. (Denoble et al.
2011) could confirm the potential involvement of the
innate immune system in osteoarthritis (OA) pathology
and OA progression by correlating synovial fluid uric
acid with IL-1ß and IL-1 and with OA severity.
Our study has several strengths and weaknesses. First of
all, this is to our knowledge the first report on such a se-
lected (high-risk) patient group with longstanding mainly
unspecific musculo-skeletal problems and HU. The com-
bination of clinical data and sonographical findings may
give some new idea about possible underlying mecha-
nisms of the patients’ complaints. Gout diagnosis was
made clinically from the patient’s charts (physician-diag-
nosed) or history (self-reported) and was not confirmed
by synovial fluid analysis which might be considered to be
a weakness of this study. On the other hand, all patients
did not have gout attacks during their hospital stay, so we
considered an invasive procedure such as synovial fluid
aspiration not to be appropriate. US was performed by an
independent blinded observer and was the only imaging
technique used to detect joint pathologies. Ultrasono-
graphic findings were compared with the clinical examina-
tions of the joints. Other imaging techniques as comparator
were not used.
The US was done in a standardized manner using a 12
joint (6 joints bilateral including the MTP I) examination
protocol modified from investigations in patients with
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for gout patients exists.
In conclusion, our study contributes some evidence that
longstanding, untreated HU might cause joint damage,
even if asymptomatic, probably presenting as diverse
musculo-skeletal complaints. Thus – if ultrasonographic
gout-specific changes are detectable – “asymptomatic hy-
peruricemia” might be better termed as “subclinical or
hidden gout”. US seems to be a suitable tool to early
detect these structural changes. Our observations might
have impact on further treatment decisions, in particular
initiating urate-lowering therapy earlier, especially in
patients with a high risk of occupational disability due to
musculo-skeletal conditions. Further interventional trials
are necessary to investigate if urate-lowering therapy has
positive effects on those patients with HU and various
musculo-skeletal problems.
Additional file
Additional file 1: Table S1. Sonographic findings of 27 patients with a
history of gout. Blue fields: patients with tophi on clinical examination;
Grey fields: joints with previous gout attacks, Abbreviations: DC=double
contour sign, HC=hyperechoic clouds, E=erosions, S=synovitis.
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